Simplifying identification testing for quality control with benchtop NMR

Identification is one of the most frequently performed tests in pharmaceutical Quality Control (QC) laboratories. Though it may seem straightforward, reliable identification requires robust, efficient procedures to maintain both quality and throughput. 

A production line in the pharma industry

Image Credit: Buonnaventura/Shutterstock.com

This whitepaper explores the advantages of using Nuclear Magnetic Resonance (NMR) for QC identification testing. It showcases how benchtop systems like the Fourier 80 enable the development of highly specific, standard-free tests with fast turnaround times, offering a compelling alternative to conventional technologies.

Download the full whitepaper here.

About Bruker BioSpin Division

The Bruker BioSpin Division designs, manufactures, and distributes advanced scientific instruments based on magnetic resonance, preclinical imaging technologies, and biosensor technologies. These include our industry-leading NMR and EPR spectrometers, imaging systems utilizing MRI, PET, SPECT, CT, Optical and MPI modalities, as well as molecular interaction technologies like SPR, switchSENSE® and single-cell Interaction Cytometry (scIC). The Division also offers integrated software solutions and automation tools to support digital transformation across research and quality control environments.

Our customers in academic, government, industrial, and pharmaceutical sectors rely on these technologies to gain detailed insights into molecular structure, dynamics, and interactions. Our solutions play a key role in structural biology, drug discovery, disease research, metabolomics, and advanced materials analysis. Recent investments in lab automation, optical imaging, and contract research services further strengthen our ability to support evolving customer needs and enable scientific innovation.


Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.net, which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.

Last updated: Oct 12, 2026 at 2:54 AM

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Bruker BioSpin Division. (2026, October 12). Simplifying identification testing for quality control with benchtop NMR. News-Medical. Retrieved on November 06, 2026 from https://www.news-medical.net/whitepaper/20251008/Simplifying-identification-testing-for-quality-control-with-benchtop-NMR.aspx.

  • MLA

    Bruker BioSpin Division. "Simplifying identification testing for quality control with benchtop NMR". News-Medical. 06 November 2026. <https://www.news-medical.net/whitepaper/20251008/Simplifying-identification-testing-for-quality-control-with-benchtop-NMR.aspx>.

  • Chicago

    Bruker BioSpin Division. "Simplifying identification testing for quality control with benchtop NMR". News-Medical. https://www.news-medical.net/whitepaper/20251008/Simplifying-identification-testing-for-quality-control-with-benchtop-NMR.aspx. (accessed November 06, 2026).

  • Harvard

    Bruker BioSpin Division. 2026. Simplifying identification testing for quality control with benchtop NMR. News-Medical, viewed 06 November 2026, https://www.news-medical.net/whitepaper/20251008/Simplifying-identification-testing-for-quality-control-with-benchtop-NMR.aspx.

Other White Papers by this Supplier

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.